Health Care Equipment

REMSleep Holdings, Inc.

REMSleep Holdings, Inc. released FY2025 Q3 earnings on November 19 (EST), actual revenue USD 7.454 K, actual EPS USD -0.0014

REMSleep Holdings, Inc. released FY2025 9 Months Earnings on November 19 (EST), actual revenue USD 12.28K, actual EPS USD -0.0017

REMSleep Holdings, Inc. released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 4.824K, actual EPS USD -0.0002

REMSleep Holdings, Inc. released FY2025 Q2 earnings on August 14 EST, actual revenue USD 4.824 K, actual EPS USD -0.0001

REMSleep Holdings, Inc. released FY2025 Q1 earnings on May 13 (EST) with actual revenue of USD 0 and EPS of USD 0

REMSleep Holdings, Inc. released FY2024 Q4 earnings on April 14, 2025 (EST) with actual revenue of USD -5.55K and EPS of USD -0.0002

REMSleep Holdings, Inc. released FY2024 annual earnings on April 14 (EST), actual revenue USD 117.19 K, actual EPS USD -0.0007

REMSleep Holdings, Inc. released FY2024 Cumulative 3Q Earnings on November 14, 2024 (EST): Revenue 122.74K USD, EPS -0.0005

REMSleep Holdings, Inc. released FY2024 Q3 earnings on November 14 (EST), with actual revenue of 37.26 K USD and EPS of -0.0001 USD

REMSleep Holdings, Inc. Obtains Patent for Nasal Ventilation System

A SPAC III Acquisition

PicoCELA

Davis Commodities

Society Pass

ECD Automotive Design

Gauzy

Bristol-Myers Squibb Company

A SPAC III ACQUISITION CORP. COM NPV CL A (SUBS/RTS)02/01/2026

Paranovus ENT Tech

Cue BioPharma

Delcath

Electromed

Abbott Laboratories

Intuitive Surgical

Boston Scientific

Stryker

IDEXX Labs

Edwards Lifesciences

Resmed

DexCom

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap